Medpace (MEDP) Competitors

IQVIA (NYSE:IQV) and Medpace (NASDAQ:MEDP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, community ranking, analyst recommendations, profitability and risk.

Do institutionals & insiders believe in IQV or MEDP?

89.6% of IQVIA shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 1.6% of IQVIA shares are owned by insiders. Comparatively, 20.3% of Medpace shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Which has higher earnings & valuation, IQV or MEDP?

IQVIA has higher revenue and earnings than Medpace. IQVIA is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IQVIA	$15.41B	2.05	$1.37B	$7.50	23.92
Medpace	$2.11B	4.57	$404.39M	$12.63	25.07

Do analysts prefer IQV or MEDP?

IQVIA presently has a consensus target price of $249.05, indicating a potential upside of 38.82%. Medpace has a consensus target price of $376.30, indicating a potential upside of 18.85%. Given IQVIA's stronger consensus rating and higher probable upside, analysts plainly believe IQVIA is more favorable than Medpace.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IQVIA	0 Sell rating(s)	4 Hold rating(s)	16 Buy rating(s)	1 Strong Buy rating(s)	2.86
Medpace	0 Sell rating(s)	8 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.38

Does the MarketBeat Community believe in IQV or MEDP?

IQVIA received 329 more outperform votes than Medpace when rated by MarketBeat users. Likewise, 68.30% of users gave IQVIA an outperform vote while only 63.31% of users gave Medpace an outperform vote.

Company	Underperform	Outperform
IQVIA	Outperform Votes 681 68.30%	Underperform Votes 316 31.70%
Medpace	Outperform Votes 352 63.31%	Underperform Votes 204 36.69%

Is IQV or MEDP more profitable?

Medpace has a net margin of 19.17% compared to IQVIA's net margin of 8.91%. Medpace's return on equity of 51.48% beat IQVIA's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IQVIA	8.91%	28.81%	7.02%
Medpace	19.17%	51.48%	20.47%

Which has more volatility & risk, IQV or MEDP?

IQVIA has a beta of 1.5, suggesting that its stock price is 50% more volatile than the S&P 500. Comparatively, Medpace has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500.

Does the media favor IQV or MEDP?

In the previous week, IQVIA had 3 more articles in the media than Medpace. MarketBeat recorded 28 mentions for IQVIA and 25 mentions for Medpace. IQVIA's average media sentiment score of 1.26 beat Medpace's score of 1.17 indicating that IQVIA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IQVIA	23 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	2 Very Negative mention(s)	Positive
Medpace	11 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IQVIA beats Medpace on 12 of the 19 factors compared between the two stocks.